PCSK9 and Alzheimer disease: Increased CSF concentrations of PCSK9, with a positive correlation with ApoE4 levels, have been reported in AD subjects, suggesting a pathophysiological link between PCSK9, apoE4, and AD (Zimetti et al., 2017).